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ABSTRACT
Objective: The objective of this research was to develop and validate a simple ultraviolet (UV) spectrophotometric method for simultaneous 
determination of sildenafil citrate and dapoxetine hydrochloride in a pharmaceutical formulation.
Methods: Two simple UV spectrophotometric methods have been developed for simultaneous determination of sildenafil citrate and dapoxetine 
hydrochloride. For both methods, stock solutions were prepared in methanol followed by the further required dilutions with methanol. Proposed 
dual-wavelength method and ratio derivative method, the wavelength of maximum absorption for sildenafil citrate and dapoxetine hydrochloride was 
292 nm and 231 nm, respectively.
Results: In both methods, the linearity range lies between 10 and 60 µg/ml for sildenafil citrate and 2–12 µg/mL for dapoxetine hydrochloride with 
their respective wavelengths. By dual-wavelength method, the percentage of sildenafil citrate and dapoxetine hydrochloride was found to be 101.3% 
and 100.3%, respectively.
Conclusion: Result obtained in this research work clearly indicated that both these methods were found to be accurate, precise, stable, and robust as 
indicated by low values of percentage relative standard deviation. Thus, the present study gives an excellent method for the determination of both the 
drugs in combined tablet formulation.
Keyword: Sildenafil citrate, Dapoxetine hydrochloride, Simultaneous estimation, Ultraviolet spectrophotometric methods.
INTRODUCTION
Sildenafil citrate (SIL) and dapoxetine hydrochloride (DAPO) are 
available in a combined pharmaceutical dosage form for the treatment 
of erectile dysfunction, have a considerable impact on the research and 
medical communities. In 1996 sildenafil citrate was patented and in May 
1998, it is launched as a first oral drug approved by the Food and Drug 
Administration in the United States. It is also used for the treatment of 
pulmonary arterial hypertension. Sildenafil citrate is white crystalline 
water-soluble powder with a molecular weight of 666.7 Dalton. 
The molecular formula is C22H30N6O4S. Chemically, designated as 
1-[[3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]
pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methyl piperazine citrate. 
Its structural formula is given in Fig. 1 [1,2].
When man arouses sexually, the parasympathetic nerves are stimulated 
leading to penile erection as result of release nitric oxide (NO) which 
works by activation of the enzyme guanylate cyclase responsible 
for converting guanosine triphosphate to 3’5’ cyclic guanosine 
monophosphate (cGMP). Sildenafil citrate selectively inhibits the 
enzyme phosphodiesterase-5A that hydrolyzes cGMP which is a potent 
vasodilator vital erection of the penis and increased the inflow of blood 
into the spongy tissue of the penis causing an erection by fascinating 
the signaling actions of NO in penile smooth muscle. The most common 
side effects of sildenafil citrate are facial flushing, headache, and upset 
stomach. Less commonly blurred vision, cyanopsia (bluish vision), or 
sensitivity to light may be briefly occur. Dapoxetine hydrochloride is 
mainly useful in erectile dysfunction as a selective serotonin reuptake 
inhibitor (SSRI). This drug is designated chemically as (S)-N, N-dimethyl-
3-(naphthalene-1-yloxy)-1 phenylpropane-1-amine with an empirical 
formula of C21H23NO and molecular weight of 305.413 g. SSRI is a class 
of compounds typically used as antidepressants in the treatment of 
depression, anxiety disorders, and some personality disorders. They can 
also sometimes be effective and used in treating impotence, premature 
ejaculation problems, and in some cases of insomnia. This drug inhibits 
neuronal reuptake of serotonin and subsequent potentiating of serotonin 
activity and increases the ejaculation time. Its structural formula is 
given in Fig. 2 [1,2]. There is a need for development and validation 
of ultraviolet (UV) analytical method for simultaneous estimation 
of dapoxetine hydrochloride and sildenafil citrate for combined 
pharmaceutical dosage form. Here, two simple UV spectrophotometric 
methods were developed and validated for their simultaneous analysis.
Experimental
Instrumentation and apparatus
Double beam UV-visible spectrophotometer (Shimadzu Corporation, 
model UV 1800) was used having two matched quartz cells with 1cm 
light path length. [3]
Reagents
Pure samples of sildenafil citrate and dapoxetine hydrochloride and 
their combination pharmaceutical preparations were collected from 
Astra Lifecare Pvt. Ltd., Ahmedabad. Methanol was used as solvents 
throughout the experiment.
Preparation of stock solution of dapoxetine hydrochloride
Accurately weighed 10 mg of dapoxetine hydrochloride was transferred 
into a 100 ml volumetric flask and dissolved in small volume of 
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Fig. 1: Sildenafil Citrate
Fig. 2: Dapoxetine Hydrochloride
Fig. 3: Calibration curve data for sildenafil citrate standard
Fig. 4: Calibration curve data for dapoxetine hydrochloride 
standard
Fig. 5: Overlay spectra of sildenafil citrate and dapoxetine 
hydrochloride
Fig. 6: Calibration curve of sildenafil citrate
Fig. 7: Ratio first derivative absorption spectra of DAPO (2–12 μg/ml
Fig. 8: Ratio first derivative absorption spectra of sildenafil citrate 
(10–60 μg/ml0029
Fig. 9: Calibration curve of dapoxetine hydrochloride
methanol. The volume was adjusted to the mark with methanol to 
obtain a final concentration of dapoxetine hydrochloride (100 µg/ml). 
1ml of this solution was transferred in a 10 ml volumetric flask, and 
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volume was adjusted to the mark with methanol, to prepare a final 
concentration of 10 µg/ml [4].
Preparation of stock solution of sildenafil citrate
Accurately weighed 10 mg of sildenafil citrate was transferred into a 
100 ml volumetric flask and dissolved in small volume of methanol. 
The volume was adjusted to the mark with methanol to obtain a final 
concentration of sildenafil citrate (100 µg/ml). 1 ml of this solution as 
transferred in a 10 ml volumetric flask and volume was adjusted to the 
mark with methanol, to prepare a final concentration of 10 µg/ml.
Dual-wavelength method
Selection of wavelength for dual wavelength
Dual-wavelength method was used for estimation of sildenafil citrate 
and dapoxetine hydrochloride; in this method, two wavelengths are 
required for one drug where one drug shows similar absorbance, but 
other drug shows the difference in absorbance. Two wavelengths were 
selected at which sildenafil citrate showed similar absorbance while 
other drug dapoxetine hydrochloride showed a considerable difference 
in absorbance. The other two wavelengths were selected such that 
dapoxetine hydrochloride showed similar absorbance while sildenafil 
citrate showed a considerable difference in absorbance (Fig.5).
Analysis of formulation
Twenty tablets (label claim of 100 mg sildenafil citrate and 60 mg 
dapoxetine hydrochloride) were weighed and finely powdered. 
Powder equivalent to 100 mg sildenafil citrate and 60 mg dapoxetine 
hydrochloride was accurately weighed and transferred to 100 ml 
volumetric flask addition of methanol and sonicated for 15 min. 
The volume was made up to mark with methanol. The solution was 
filtered through Whatman filter paper (0.45 μ). From this solution, 
1ml was transferred to the 10 ml volumetric flask and volume made 
up to the mark to give a solution containing 10 µg/ml sildenafil 
citrate and 6 µg/ml dapoxetine hydrochloride. This solution 
was used for the estimation of sildenafil citrate and dapoxetine 
hydrochloride [5-7].
Ratio derivative method
Selection of analytical wavelength
Zero-order spectra of standard solution of sildenafil citrate and 
dapoxetine hydrochloride were recorded and further, spectra were 
divided by 8 µg/ml dapoxetine hydrochloride and 40 µg/mL sildenafil 
citrate, respectively, and these ratio spectra of sildenafil citrate and 
dapoxetine hydrochloride were converted into first derivative, and 
absorbance at wavelength 242.68nm and 239.58 nm was determined for 
estimation sildenafil citrate and dapoxetine hydrochloride, respectively.
Analysis of formulation
Twenty tablets (label claim of 100 mg sildenafil citrate and 60 mg 
dapoxetine hydrochloride) were weighed and finely powdered. 
Powder equivalent to 100 mg sildenafil citrate and 60 mg dapoxetine 
hydrochloride was accurately weighed and transferred to the 100 ml 
volumetric flask followed by addition of methanol and sonicated for 
15 min. The volume was made up to mark with methanol. The solution 
was filtered through Whatman filter paper (0.45 μ). From this solution, 
1ml was transferred, to 10 ml volumetric flask and diluted up to mark 
to give a solution containing 10 µg/ml sildenafil citrate and 6 µg/ml 
dapoxetine hydrochloride. This solution was used for the estimation of 
sildenafil citrate and dapoxetine hydrochloride.
DETERMINATION OF SILDENAFIL CITRATE AND DAPOXETINE  
HYDROCHLORIDE BY RATIO FIRST DERIVATIVE 
SPECTROPHOTOMETRIC METHOD
The standard stock solution was used for the preparation of the solution 
in the calibration range of 10–50 µg/mL of sildenafil citrate and 2–12 µg/
mL of dapoxetine hydrochloride in methanol in 10 ml of volumetric flask. 
Selection of devisor concentration is done by the division of the mixture’s 
spectrum by the spectrum of one fixed component named “divisor.” Then, 
the derivative ratio spectrum of that mixture will be independent on that 
component “divisor,” and the other component can be determined with 
no interference. Different concentrations of sildenafil citrate (10, 20, 30, 
40, 50, and 60 µg/ml) and of dapoxetine hydrochloride (2, 4, 6, 8, 10, 
and 12 µg/ml) were tested as a divisor but the concentrations 40 µg/
ml of sildenafil citrate and 8 µg/ml of dapoxetine hydrochloride gave 
minimum noise in ratio spectra, best linearity, and maximum sensitivity. 
Final selected divisor concentration for sildenafil citrate (8 µg/ml) and 
dapoxetine hydrochloride (40 µg/ml) [9].
RESULTS
Dual-wavelength method
The overlay spectrum of sildenafil citrate and dapoxetine hydrochloride 
at different concentrations revealed that at 213.2 nm and 226.09 nm 
different concentrations of sildenafil citrate showed similar absorbance 
whereas dapoxetine hydrochloride showed a significant difference 
in the absorbance. In a similar manner, at 242.09 nm and 271.70 nm, 
different concentrations of dapoxetine hydrochloride showed similar 
absorbance whereas sildenafil citrate showed a significant difference 
in absorbance. Considering above facts, wavelength 242.09 nm and 
271.70 nm were selected for the estimation of sildenafil citrate while 
213.2 nm and 226.09 nm were selected for the estimation of dapoxetine 
hydrochloride (Table 1).
Linearity
The linearity was assessed by ordinary linear regression analysis. The 
constructed calibration curve was linear over the concentration range 
of 2–12 µg/ml and 10–60 µg/ml, the linear regression equation was 
Y=0.0534x–0.0329 and Y=0.0153x–0.0808 with regression coefficient 
of 0.9954 and 0.9991 for dapoxetine and sildenafil, respectively. The 
result shows that the calculated χ2 value is less than the critical value 
at 95% confidence interval, χ2 (0.05, 5) =9.488; thus, indicating that the 
variance of response is homogeneous (Figs. 3,4, 6 and 9).
Table 2: Linear regression parameters for dapoxetine 





Linearity range (µg/ml) 10–60 µg/ml 2–12 µg/ml
Correlation coefficient (r2) 0.9995 0.9965
Slope±SDb (Sb) 3.2965±0.0011 0.1336±0.00023
Confidence limit of slope 3.1919–3.4011 0.1226–0.1444
Intercept±SDb (Sa) 20.185±0.00403 0.0627±0.00177
Confidence limit of intercept 16.122–24.256 0.02257–0.1479
LOD (µg/ml) 0.00404 0.0439
LOQ (µg/ml) 0.01224 0.1330
Bartlett’s testa (χ2) 0.8247 0.8959
bMean of five determinations, ashould be <5.991 at 95% confidence interval, 
n=5. LOD: Limit of detection, LOQ: Limit of quantitation
Table 1: Linear regression parameters for dapoxetine 





Linearity range (µg/ml) 10–60 2–12
Correlation coefficient (r2) 0.9991 0.9954
Slope±SDb (Sb) 0.0153±0.00015 0.0053±0.00023
Confidence limit of slope 0.00143–0.0160 0.00507–0.0056
Intercept±SDb (Sa) 0.0808±0.00245 0.0329±0.00146
Confidence limit of intercept 0.0557–0.1060 0.0483–0.0584
LOD (µg/ml) 0.5282 0.0904
LOQ (µg/ml) 1.6006 0.2741
Bartlett’s testa (χ2) 0.8698 1.0673
bMean of five determinations, ashould be<5.991 at 95% confidence interval, 
LOD: Limit of detection, LOQ: Limit of quantitation
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Limit of detection (LOD) and limit of quantitation (LOQ)
LOD and LOQ for dapoxetine hydrochloride were found to be 
0.09047 µg/ml and 0.27416 µg/ml and for sildenafil citrate were found 
to be 0.5282 µg/ml and 1.6006 µg/ml, respectively.
Precision
Results of intraday show percentage relative standard deviation (RSD) 
below 0.923 and 0.955 while interday results show percentage RSD 
below 0.650 and 1.777, respectively, for sildenafil and dapoxetine. 
The values were <2% thus demonstrating good repeatability and 
reproducibility of the method.
Accuracy
The proposed method afforded recovery of 100.51–101.91% after 
spiking the standard drug at three concentration levels of 50, 100, and 
150%. The values of percentage recovery and percentage RSD for both 
drugs percentage RSD were found to be <2% which indicate that the 
proposed method was accurate [10].
Ratio derivative method
Ratio spectra of sildenafil citrate were obtained by dividing the zero-
order spectra of sildenafil citrate (10–60 µg/ml) by the spectrum 
of a standard solution of dapoxetine hydrochloride (8 µg/ml). The 
obtained ratio spectra of sildenafil citrate were converted into first-
order derivative (D1) spectra. Likewise, a ratio spectrum of dapoxetine 
hydrochloride was obtained by dividing zero-order spectra of dapoxetine 
hydrochloride (2–12 µg/ml) by the spectrum of standard solution 
of sildenafil citrate (40 µg/ml). The obtained spectra of dapoxetine 
hydrochloride were converted into the first-order derivative (D1) spectra 
with the interval of ∆λ=8 nm and scaling factor 20. The concentrations 
of selected analyte were quantified by measuring the amplitude maxima 
of the respective analyte from their first-order derivative (D1) spectrum 
at λ of 242.68 nm and 239.58 nm for sildenafil citrate and dapoxetine 
hydrochloride, respectively [7,8] (Table 2 and Figs.7,8).
Linearity
The sildenafil citrate and dapoxetine hydrochloride showed good 
correlation coefficient r2=0.9995 and r2=0.9968, respectively, in the given 
concentration range of 10–60 µg/ml for sildenafil citrate and 2–12 µg/ml 
for dapoxetine hydrochloride. The result shows that the calculated χ2 
value is less than the critical value at 95% confidence interval, χ2 (0.05, 
5) =9.488; thus indicating that the variance of response is homogeneous.
LOD and LOQ
LOD and LOQ for dapoxetine hydrochloride were found to be 
0.0439 µg/ml and 0.1330 µg/ml and for sildenafil citrate were found 
to be 0.0040 µg/ml and 0.1224 µg/ml, respectively, individually high 
sensitivity of the method.
Precision
Results of intraday precision show percentage RSD below 0.005 and 
0.077, while interday precision results show percentage RSD below 
0.015 and 0.222, respectively, for sildenafil citrate and dapoxetine 
hydrochloride. The values were <2%, thus demonstrating good 
repeatability and reproducibility of the method.
Accuracy
The proposed method afforded recovery of 100.40–101.26% after 
spiking the standard drug at three concentration levels of 50, 100, and 
150%. The values of percentage recovery and percentage RSD for both 
drugs percentage RSD were found to be <2% which indicate that the 
proposed method was accurate.
DISCUSSION
Sildenafil citrate and dapoxetine hydrochloride are available in the 
combined pharmaceutical dosage form. Earlier, the various UV analytical 
methods for sildenafil citrate [5,11,12,13] and dapoxetine hydrochloride 
[1,6,14] have been reported for bulk drug or in a combination of other 
drugs, but till now no analytical research work on the combination of 
sildenafil citrate and dapoxetine hydrochloride has been reported. Thus, 
this research work is useful for simultaneous estimation of dapoxetine 
hydrochloride and sildenafil citrate for combined pharmaceutical dosage 
form. The standard deviation and RSD of the methods are low, indicating 
a high degree of precision of the methods. The developed methods are 
simple, rapid, precise, and accurate and can be employed for the routine 
estimation of sildenafil citrate and dapoxetine hydrochloride.
CONCLUSION
The introduction of sildenafil citrate and dapoxetine hydrochloride has had 
a considerable impact on the research and medical communities. It has led 
to an increasing interest in sexual medicine, both in academia, in clinical 
practice and the pharmaceutical industry. Several large pharmaceutical 
companies are searching for new treatments for male erectile dysfunction 
and premature ejaculation. In the future, we can anticipate a wide array of 
treatments for male erectile disorder and premature ejaculation hopefully 
some breakthroughs in the treatment of other sexual disorders.
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